Recruiting Advanced Solid Tumors Studies in Arlington
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1305/BNT325 in subjects with advanced solid tumors....
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
This is an open-label, dose escalation and expansion study to evaluate the safety, tolerability, PK, and biological activity of VT3989 administered, alone or in combination, once daily in patients wit...
About Advanced Solid Tumors Clinical Trials in Arlington
Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.
There are currently 2 advanced solid tumors clinical trials recruiting participants in Arlington, VIRGINIA. These studies are seeking a combined 1,459 participants. Research is being sponsored by DualityBio Inc., Vivace Therapeutics, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Advanced Solid Tumors Clinical Trials in Arlington — FAQ
Are there advanced solid tumors clinical trials in Arlington?
Yes, there are 2 advanced solid tumors clinical trials currently recruiting in Arlington, VIRGINIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Arlington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Arlington research site will contact you about next steps.
Are clinical trials in Arlington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Arlington studies also compensate for your time and travel.
What advanced solid tumors treatments are being tested?
The 2 active trials in Arlington are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.
Data updated March 2, 2026 from ClinicalTrials.gov